| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.45 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG) are safe procedures that may present sub-optimal results in superobesity (SO). A meta-analysis was performed aiming to summarize the available evidence on weight loss (primary outcome) and comorbidities resolution of LRYGB and LSG in patients with SO (BMI ≥ 50 kg/m2). From the 16 included studies, 7 integrated the meta-analysis. LRYGB showed a significantly higher weight loss at 6 to 12-months, but not after 24 months and a higher dyslipidemia resolution at 12 months. When compared with LSG, LRYGB achieved better weight loss after 6 and 12 months and higher dyslipidemia resolution after 1 year. There were no significant differences for resolution of the other co-morbidities studied.
Description
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021
Keywords
Bariatric surgery Comorbidity resolution LRYGB LSG Laparoscopic Roux-en-Y gastric bypass Laparoscopic sleeve gastrectomy Meta-analysis Super obesity Weight loss
Pedagogical Context
Citation
Obes Surg. 2021 Oct 12
Publisher
Springer Nature